The DOI matches its Crossref record; 18 of the 19 references it cites were found in a registry or an index.
High-dose pilot study with the novel progestogen dienogestin patients with endometriosis
Abstract
High-dose dienogest (20 mg/day) was used for the treatment of endometriosis in women aged 18-52 years after laparoscopic and histological diagnosis of endometriosis and staging according to the revised American Fertility Society criteria. Treatment efficacy was analyzed objectively by second-look laparoscopy, and serum hormone measurements and evaluation of endometriosis-related symptoms were performed done and side-effects recorded. Compared with other high-dose progestin therapies, treatment with dienogest was shown to be effective even in stage IV endometriosis. The side-effect profile of the high-dose dienogest treatment appears to be highly favorable compared with other treatments. Neither the menopausal symptoms caused by therapy with gonadotropin-releasing hormone agonists nor the adverse androgen-related effects induced by danazol were observed. Therefore, long-term high-dose dienogest therapy can be recommended particularly for women with progressive endometriosis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dienogest is a selective progestin that combines the pharmacological properties of 19-norprogestins and progesterone derivatives, offering a pronounced progestogenic effect at the endometrium with an absence of androgenicity and moderate suppression of ovarian activity”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Schindler et al., 2006
In the citing paper
“The outcomes from this study support previous studies which investigated the efficacy of dienogest in relieving symptoms of endometriosis (Cosson et al., 2002;Schindler et al., 2006;Momoeda and Taketani, 2007;Seitz et al., 2008;Harada et al., 2009;Ko ¨hler et al., 2010).”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Schindler et al., 2006
In the citing paper
“The safety and tolerability findings from the current trial support the findings of previous studies of dienogest in endometriosis (Ko ¨hler et al., 1989(Ko ¨hler et al., , 2010;;Schindler et al., 2006;Seitz et al., 2008;Harada et al., 2009).”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Schindler et al., 2006
In the citing paper
“Dienogest, in contrast, appears to have no relevant effect on lipids (Ko ¨hler et al., 1989;Schindler et al., 2006;Seitz et al., 2008) and lacks androgenic side effects (Oettel et al., 1999;Schindler et al., 2003).”
From Dienogest is as effective as leuprolide acetate in treating the painful symptoms of endometriosis: a 24-week, randomized, multicentre, open-label trial (2010) · cites this paper as Schindler et al., 2006
Citations
Cites
Revised American Society for Reproductive Medicine classification of endometriosis: 1996
American Society for Reproductive Medicine (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)81391-x · Cited by 3,018
Revised American Fertility Society Classification of Endometriosis: 1985
(1985) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48430-x · Cited by 1,803
Vercellini, P., Trespidi, L., Colombo, A., Vendola, N., Marchini, M., & Crosignani, P. G. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56039-7 · Cited by 311
Telimaa, S., Puolakka, J., & Kauppila, A. (1987) · Gynecological Endocrinology · doi:10.3109/09513598709082692 · Cited by 241
Progestins for symptomatic endometriosis: a critical analysis of the evidence
Vercellini, P., Cortesi, I., & Crosignani, P. G. (1997) · Fertility and Sterility · doi:10.1016/s0015-0282(97)00193-3 · Cited by 232
Cosson, M., Querleu, D., Donnez, J., Madelenat, P., Konincks, P., Audebert, A., & Manhes, H. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03270-8 · Cited by 153
Pain symptoms associated with endometriosis.
Fedele, L., Bianchi, S., Bocciolone, L., Nola, G. D., & Parazzini, F. (1992) · PubMed · Cited by 146
Pathophysiology, diagnosis and treatment of endometriosis.
Schindler, A. E. (2004) · PubMed · Cited by 139
Self-citationShaw, R. W. (1992) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55205-4 · Cited by 119
Shaw, R. W. (1992) · The Lancet · doi:10.1016/0140-6736(92)92960-n · Cited by 84
Research works printed but not linked: 8
- Schindler A E, 2004, Minerva Ginecol, 56, 419
- Regidor P A, 1996, Zentralbl Gynakol, 118, 283
- Oettel M, 1995, Drugs Today, 31, 517
- Taubert H D, 1995, Kontrazeption mit Hormonen2nd ed
- Fedele L, 1992, Obstet Gynecol, 79, 767
- Moore C, 1999, Drugs Today, 35, 41
- Lemay A, 1995, Progress in the management of endometriosis, 265
- Moghissi K S, 1976, Obstet Gynecol, 47, 265
Cited by
Strowitzki, T., Marr, J., Gerlinger, C., Faustmann, T., & Seitz, C. (2010) · Human Reproduction · doi:10.1093/humrep/dep469 · Cited by 381
“The safety and tolerability findings from the current trial support the findings of previous studies of dienogest in endometriosis (Köhler et al., 1989, 2010; Schindler et al., 2006; Seitz et al., 2008; Harada et al., 2009).”
BackgroundResultInfluentialThe role of melatonin as an antioxidant in the follicle
Tamura, H., Takasaki, A., Taketani, T., Tanabe, M., Kizuka, F., Lee, L., Tamura, I., Maekawa, R., Aasada, H., Yamagata, Y., et al. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-5 · Cited by 276
“In 1993, melatonin was discovered to function as a direct free radical scavenger when it was shown to detoxify the highly reactive hydroxyl radical (·OH) [35,36].”
BackgroundStrowitzki, T., Faustmann, T., Gerlinger, C., & Seitz, C. (2010) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2010.04.002 · Cited by 227
“The improvement in EAPP associated with dienogest was accompanied by an acceptable safety and tolerability profile, consistent with observations in previous reports [10–16].”
ResultSasagawa, S., Shimizu, Y., Kami, H., Takeuchi, T., Mita, S., Imada, K., Kato, S., & Mizuguchi, K. (2008) · Steroids · doi:10.1016/j.steroids.2007.10.003 · Cited by 177
Köhler, G., Faustmann, T. A., Gerlinger, C., Seitz, C., & Mueck, A. O. (2010) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2009.08.020 · Cited by 159
“[10], dienogest has been investigated in endometriosis at doses up to 2×10 mg/day [15].”
Background
Metadata
- Authors
- Schindler, A. E., Christensen, B., Henkel, A., Oettel, M., & Moore, C.
- Affiliations
- Essen University Hospital (DE)
- Corresponding author
- Schindler, A. E.
- Venue
- Gynecological Endocrinology
- Publisher
- Informa UK Limited
- Published
- 2006-01
- Volume
- 22
- Issue
- 1
- Pages
- 9-17
- ISSN
- 0951-3590 (ISSN-L)
- 1473-0766
- OpenAlex
- W2072530881
- Cited by
- 53
- References
- 19
- Citations by year
- 2024: 4 · 2023: 1 · 2020: 2 · 2017: 6 · 2016: 2 · 2015: 1 · 2014: 2 · 2013: 3 · 2012: 9
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gynecological Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
- Health Sciences › Medicine › Obstetrics and Gynecology › Ectopic Pregnancy Diagnosis and Management
- Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
- Keywords
- dienogest, endometriosis, stage IV endometriosis, second-look laparoscopy, treatment efficacy, adverse effects, menopausal symptoms, danazol, GnRH agonist
- MeSH terms
- Adult, Endometriosis, Female, Hormone Antagonists, Humans, Nandrolone, Pilot Projects, Treatment Outcome, Statistics, Nonparametric
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High-dose pilot study with the novel progestogen dienogestin patients with endometriosis. https://app.cochat.ai/papers/10.1080/09513590500431482
- The paper
- Schindler, A. E., Christensen, B., Henkel, A., Oettel, M., & Moore, C. (2006). High-dose pilot study with the novel progestogen dienogestin patients with endometriosis. Gynecological Endocrinology. https://doi.org/10.1080/09513590500431482
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.